FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386347033> ?p ?o ?g. }

• W4386347033 endingPage "1386" @default.
• W4386347033 startingPage "1374" @default.
• W4386347033 abstract "Context Jiang-Zhi-Ning (JZN), a traditional Chinese medicinal formula, is used to treat hyperlipidemia in clinics.Objective To screen the hypolipidemic “bioequivalent substance system (BSS)” of JZN and elucidate the potential hypolipidemic mechanism.Materials and methods In vitro, the TG content in HepG2 cells was determined after the intervention of the combination of advantageous components (CAC) by uniform design. In vivo, hyperlipidemia models were established by Triton WR-1339 (400 mg/kg; i.p.) in male ICR mice, and corresponding treatments were administered via oral administration once. The mice were divided into 12 groups (n = 5): control, hyperlipidemic model, simvastatin (positive control, 20 mg/kg), gradient doses of JZN granules (2, 4 and 8 g/kg) and the hypolipidemic effective extraction (HEE) of JZN (120, 240 and 480 mg/kg) and CAC groups (20, 40 and 160 mg/kg). Serum TC, TG, LDL-C and HDL-C were performed after 24 h. Transcriptomics and qRT–PCR technology were used to explore the mechanism of the “BSS” of JZN.Results In vitro, the ratio of CAC was determined. CAC could reduce the TG content in HepG2 cells (77.21%). Compared with the model group, the high dose of CAC could markedly decrease the levels of TC (61.86%), TG (105.54%) and LDL-C (39.38%) and increase the level of HDL-C (232.67%). CAC was proved to be the “BSS”. Transcriptomics and qRT–PCR analysis revealed CAC regulated non-alcoholic fatty liver disease, bile secretion, PPAR and adipocytokine signalling pathway.Discussion and conclusions These findings provided new feasible ideas and methods for the elucidation of the pharmacodynamic material basis." @default.
• W4386347033 created "2023-09-02" @default.
• W4386347033 creator A5000219380 @default.
• W4386347033 creator A5009509819 @default.
• W4386347033 creator A5014967397 @default.
• W4386347033 creator A5023487179 @default.
• W4386347033 creator A5040326068 @default.
• W4386347033 creator A5050054317 @default.
• W4386347033 creator A5076235010 @default.
• W4386347033 creator A5079355805 @default.
• W4386347033 creator A5079809318 @default.
• W4386347033 creator A5086664284 @default.
• W4386347033 creator A5091103295 @default.
• W4386347033 date "2023-09-01" @default.
• W4386347033 modified "2023-10-01" @default.
• W4386347033 title "Optimization of the proportions of advantageous components in the hypolipidemic “bioequivalent substance system” of Jiang-Zhi-Ning and its mechanism of action" @default.
• W4386347033 cites W1970930356 @default.
• W4386347033 cites W1982385275 @default.
• W4386347033 cites W1993837162 @default.
• W4386347033 cites W1995912416 @default.
• W4386347033 cites W2003326278 @default.
• W4386347033 cites W2017009530 @default.
• W4386347033 cites W2021307559 @default.
• W4386347033 cites W2036852230 @default.
• W4386347033 cites W2054508985 @default.
• W4386347033 cites W2073636275 @default.
• W4386347033 cites W2093656658 @default.
• W4386347033 cites W2098094265 @default.
• W4386347033 cites W2117533325 @default.
• W4386347033 cites W2624747153 @default.
• W4386347033 cites W2802683121 @default.
• W4386347033 cites W2989895151 @default.
• W4386347033 cites W2990261939 @default.
• W4386347033 cites W3021898850 @default.
• W4386347033 cites W3098138308 @default.
• W4386347033 cites W3132075439 @default.
• W4386347033 cites W3164547767 @default.
• W4386347033 cites W4210641545 @default.
• W4386347033 cites W4295211227 @default.
• W4386347033 cites W4311083213 @default.
• W4386347033 cites W766306784 @default.
• W4386347033 doi "https://doi.org/10.1080/13880209.2023.2243999" @default.
• W4386347033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37655554" @default.
• W4386347033 hasPublicationYear "2023" @default.
• W4386347033 type Work @default.
• W4386347033 citedByCount "1" @default.
• W4386347033 countsByYear W43863470332023 @default.
• W4386347033 crossrefType "journal-article" @default.
• W4386347033 hasAuthorship W4386347033A5000219380 @default.
• W4386347033 hasAuthorship W4386347033A5009509819 @default.
• W4386347033 hasAuthorship W4386347033A5014967397 @default.
• W4386347033 hasAuthorship W4386347033A5023487179 @default.
• W4386347033 hasAuthorship W4386347033A5040326068 @default.
• W4386347033 hasAuthorship W4386347033A5050054317 @default.
• W4386347033 hasAuthorship W4386347033A5076235010 @default.
• W4386347033 hasAuthorship W4386347033A5079355805 @default.
• W4386347033 hasAuthorship W4386347033A5079809318 @default.
• W4386347033 hasAuthorship W4386347033A5086664284 @default.
• W4386347033 hasAuthorship W4386347033A5091103295 @default.
• W4386347033 hasBestOaLocation W43863470331 @default.
• W4386347033 hasConcept C112705442 @default.
• W4386347033 hasConcept C126322002 @default.
• W4386347033 hasConcept C134018914 @default.
• W4386347033 hasConcept C139572402 @default.
• W4386347033 hasConcept C150903083 @default.
• W4386347033 hasConcept C151730666 @default.
• W4386347033 hasConcept C185592680 @default.
• W4386347033 hasConcept C202751555 @default.
• W4386347033 hasConcept C207001950 @default.
• W4386347033 hasConcept C2776120743 @default.
• W4386347033 hasConcept C2776329913 @default.
• W4386347033 hasConcept C2778163477 @default.
• W4386347033 hasConcept C2778772119 @default.
• W4386347033 hasConcept C2778913445 @default.
• W4386347033 hasConcept C2779091943 @default.
• W4386347033 hasConcept C2779134260 @default.
• W4386347033 hasConcept C2779343474 @default.
• W4386347033 hasConcept C42404028 @default.
• W4386347033 hasConcept C55493867 @default.
• W4386347033 hasConcept C555293320 @default.
• W4386347033 hasConcept C556039675 @default.
• W4386347033 hasConcept C71924100 @default.
• W4386347033 hasConcept C86803240 @default.
• W4386347033 hasConcept C98274493 @default.
• W4386347033 hasConceptScore W4386347033C112705442 @default.
• W4386347033 hasConceptScore W4386347033C126322002 @default.
• W4386347033 hasConceptScore W4386347033C134018914 @default.
• W4386347033 hasConceptScore W4386347033C139572402 @default.
• W4386347033 hasConceptScore W4386347033C150903083 @default.
• W4386347033 hasConceptScore W4386347033C151730666 @default.
• W4386347033 hasConceptScore W4386347033C185592680 @default.
• W4386347033 hasConceptScore W4386347033C202751555 @default.
• W4386347033 hasConceptScore W4386347033C207001950 @default.
• W4386347033 hasConceptScore W4386347033C2776120743 @default.
• W4386347033 hasConceptScore W4386347033C2776329913 @default.
• W4386347033 hasConceptScore W4386347033C2778163477 @default.
• W4386347033 hasConceptScore W4386347033C2778772119 @default.
• W4386347033 hasConceptScore W4386347033C2778913445 @default.

• next